In rare instances, recurrent ventricular tachycardia may continue in spite of all therapeutic measures, including combinations of antiarrhythmic agents in maximum doses. In these circumstances, sympathectomy was performed in 5 patients, 4 with ischaemic heart disease, in an attempt to control paroxysmal ventricular tachycardia which had repeatedly occurred for from 6 weeks to 24 with recurrent ventricular tachycardia secondary to coronary artery disease or myocarditis. In addition, I2 patients with recurrent ventricular tachycardia after myocardial infarction have been followed up to assess the effect of infarctectomy.
In rare instances, recurrent ventricular tachycardia may continue in spite of all therapeutic measures, including combinations of antiarrhythmic agents in maximum doses. In these circumstances, sympathectomy was performed in 5 patients, 4 with ischaemic heart disease, in an attempt to control paroxysmal ventricular tachycardia which had repeatedly occurred for from 6 weeks to 24 months. Abolition of the abnormal veniricular activity was obtained in 2 patients who have remainedfreefrom arrhythmia for 2 to 8years. The operation had no effect on 2 patients, and only a temporary effect on one. In another I2 patients, a focal asynergic area (3 patients) or ventricular aneurysm (9 patients) was resected in order to control recurrent ventricular tachycardia after myocardial infarction. Abolition of the ventricular irritability was obtained in 7 patients, all remaining wellfrom I month to I years after the operation. Three patients died in the immediate postoperative period. A temporary effect was seen in 2 patients, of whom i was later reported to have died.
Ventricular tachycardia is a serious arrhythmia and is a manifestation of underlying ischaemic heart disease, severe congestive heart failure, myocarditis, or drug intoxication. Antiarrhythmic drugs, electrical countershock, or rapid electrical pacing are usually successful in controlling the majority of episodes (Gianelly et al., I967; DeSanctis, I965; Friedberg, Lyon, and Donoso, I970) . Recurrent attacks of ventricular tachycardia may, however, continue in spite of all these therapeutic measures, and the mortality of the patients with these arrhythmias is greater than that of patients with comparable conditions but without these arrhythmias (Armbrust and Levine, I950 with recurrent ventricular tachycardia secondary to coronary artery disease or myocarditis. In addition, I2 patients with recurrent ventricular tachycardia after myocardial infarction have been followed up to assess the effect of infarctectomy.
Patients and methods
The case records of I7 patients undergoing operations for recurrent ventricular tachycardia were reviewed. For the present purpose, recurrent ventricular tachycardia denotes paroxysmal tachycardia of longer duration, terminated either by pharmacological or electrical intervention and reappearing spontaneously within minutes to hours. All patients failed to respond to prophylactic regimens including procainamide, quinidine sulphate, diphenylhydantoin sulphate, and propranolol, in various combinations.
The patients were men, varying in age from 26 to 66 years. The time intervals between the first attack of ventricular tachycardia and the operation varied from a few weeks to several years. A total of 5 patients underwent bilateral thoracic sympathectomy (Table i) . Of these, 4 patients had coronary artery disease (Cases I-4), and one patient had cardiomyopathy of undetermined aetiology (Case 5). None of these patients had electrocardiographic changes suggesting the presence of ventricular aneurysm, but left ventricular angiography was not done in all cases. The remaining I2 patients (Table 2) had well-documented ischaemic heart disease with clinical and electrocardiographic evidence of recent (Cases I-3) or old (Cases 4-I2) myocardial infarction. Left heart catheterization with ventricular cineangiography revealed either localized akinesis or dyskinesis of a portion of anterior left ventricular wall or apex, or a true ven-Surgical treatment of recurrent ventricular tachycardia I33 surgical intervention. They all had sinus rhythm on In the sympathectomized group (Table i) there a maintenance dose of digitoxin and a small dose of was one early death in hospital due to ventricular procainamide. Two of them (Cases 9 and io) confibrillation (Case 2). The remaining 4 patients tinued to have symptoms of heart failure and comwere discharged from the hospital alive. In plained of palpitation. Of these 2 patients, I was one of them (Case i) recurrent episodes of later reported to have died suddenly at home after ventricular tachycardia continued unchanged. an episode suggestive of ventricular fibrillation. The Another patient (Case 3) showed temporary remaining 7 patients, comprising nearly two-thirds relief from arrhythmia. Both these patients were of this group, have been followed for i month to ij later reported to have died suddenly in their years. They all have stable sinus rhythm without The use of thoracic sympathectomy in the treatment of patients with ventricular tachycardia is based on the concept that myocardial catecholamines are directly involved in the genesis of ventricular ectopic activity. Sympathetic stimulation may also be assumed to lower the threshold for ventricular arrhythmias.
In animal experiments, surgical division of the sympathetic nerve supply to the heart decreased the incidence of ventricular fibrillation after coronary artery ligation (Harris, Estandia, and Tillotson, I951), while results from other studies were less conclusive (Yodice, I941) . In man, recurrent supraventricular tachycardia was successfully treated by bilateral sympathectomy in two patients reported by Leriche and Fontaine (I929) , and a beneficial effect of the operation was also noted in a series of patients with paroxysmal atrial tachycardia by White, Smithwick, and Simeone (I952). Cardiac sympathectomy also proved effective in inhibiting the recurrence of ventricular tachycardia in solitary cases reported by Estes and Izlar (I96I) and by Zipes et al. (I968) . In our series, sympathectomy abolished ventricular tachyarrhythmia in 2 out of 5 patients, gave temporary relief in i patient, and had no effect on the remaining 2 patients. Apparently, sympathectomy under certain circumstances may prove effective in preventing ventricular arrhythmias, but the precise role and value of this therapy remains to be determined.
The rationale for surgical resection of an infarcted area in our patients was based on the assumption that an ischaemic zone represents a focus of electrical instability. It is likely that the dysrhythmias arise in the ventricle at the junction between wellvascularized and poorly vascularized myocardium, though this has never been definitely demonstrated. The possibility of circus movement (re-entry) occurring around the infarcted zone must also be considered; surgical intervention may interrupt the re-entry mechanism. Animal experiments have shown that resection of the focal asynergic areas after coronary artery ligation leads to stability of rhythm and easier ventricular defibrillation (Glass et As shown in our study, patients in whom recurrent ventricular tachycardia is associated with the existence of a left ventricular aneurysm may obtain considerable benefit from aneurysmectomy. In most of the patients, the transition from multiple potentially lethal episodes before operation to complete freedom from dysrhythmia after operation was striking. In a smaller group of these patients, the operation decreased the incidence of ectopic ventricular activity, but was not fully effective in the control of life-threatening ventricular arrhythmias. The results were less obvious in a small group of patients in whom infarctectomy was performed as an emergency operation in the acute phase of myocardial infarction. At present, since the role of surgery in treating such patients is ill defined and the risks are high, it should be considered only as a last therapeutic resort.
